Bellevue Group AG (BBN) CHF0.10
Bellevue Group AG is a Switzerland-based holding company that is active in the provision of investment banking, private banking, and asset management and consulting services, for both private and institutional clients. The Group is divided into two segments, Bank am Bellevue and Asset Management. The Bank am Bellevue segment offers investment research, individual advisory services, over the counter (OTC) derivatives, structured products, brokerage, block trades and share placement, and corporate finance services. The Asset Management segment focuses on management of equity portfolios for selected regional and sector strategies, and on institutional assets. In September 2014, it concluded the acquisition of Adamant Biomedical Investments AG from Zuercher Kantonalbank. The Company’s wholly owned subsidiaries include Bank am Bellevue AG, BAB Management NV, Bellevue Asset Management AG, Asset Management BaB NV, StarCapital AG, Bellevue Research Inc and Bellevue Capital NV, among others.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.